Category
Blood disorders
Sub Category
Hemophilia
Study Name
An Open-Label, Multicenter, Evaluation of the Safety and Efficacy of Recombinant Coagulation Factor lX Fc Fusion Protein (rFlXFc; BllB029) in the Prevention and Treatment of Bleeding in Previously Untreated Patients with Severe Hemophilia B
Principal Investigator
Roshni Kulkarni, MD
Study Information
Contact for Questions
517-364-5440

Site view: at a glance